The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly/ImClone; Novartis; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Lilly/ImClone; Pfizer; Roche/Genentech
Pazopanib (P) or placebo in completely resected stage I NSCLC patients: Survival results of the phase II trial IFCT-0703.
 
Benjamin Besse
Research Funding - GlaxoSmithKline (Inst)
 
Julien Mazières
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly/ImClone; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech
Research Funding - Puma Biotechnology; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Laureen Ribassin-Majed
No Relationships to Disclose
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Radj Gervais
No Relationships to Disclose
 
Lionel Moreau
No Relationships to Disclose
 
Henri Berard
No Relationships to Disclose
 
Didier Debieuvre
Honoraria - Boehringer Ingelheim; Chugai Pharma; Lilly; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Boehringer Ingelheim; MSD; Pfizer; Roche Pharma AG
Research Funding - Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche Pharma AG
 
Oliver Molinier
No Relationships to Disclose
 
Denis Moro-Sibilot
No Relationships to Disclose
 
Pierre Jean Souquet
Honoraria - AstraZeneca; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Lilly/ImClone; PFIZER; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca; boehringer ingelheim; Lilly/ImClone; pfizer; Roche/Genentech
Research Funding - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; GlaxoSmithKline; LILLY (Inst); Novartis; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - LILLY; PFIZER
 
Jean-Pierre Pignon
No Relationships to Disclose
 
Elodie Amour
No Relationships to Disclose
 
Aljosa Celebic
No Relationships to Disclose
 
Franck Morin
No Relationships to Disclose
 
Bernard Milleron
No Relationships to Disclose
 
Gerard Zalcman
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche
 
Jean-Charles Soria
Consulting or Advisory Role - GlaxoSmithKline